Elimination of extrachromosomal c-myc genes by hydroxyurea induces apoptosis

Apoptosis

Volumn 4, Issue 3, 1999, Pages 163-167

  Petit, T ^b   Davidson, K ^b   Izbicka, E ^b   Von Hoff, D D ^a  

^a CTRC Institute for Drug Development   (United States)

^b NONE

Author keywords

Apoptosis; Extrachromosomal c myc genes; Hydroxyurea

Indexed keywords

ACRIDINE ORANGE; ETHIDIUM BROMIDE; EXTRACHROMOSOMAL DNA; HYDROXYUREA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0032813375     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009606421419     Document Type: Article

References (25)

1. Yarbro JW. Mechanism of action of hydroxyurea. Semin Oncol 1992; 19: 1-10.
2. Von Hoff DD, Waddelow T, Forseth B, Davidson K, Scott J, Wahl G. Hydroxyurea accelerates loss of extrachromosomally amplified genes from tumor cells. Cancer Res 1991; 51: 6273-6279.
3. Abken H. Extrachromosomal DNA elements in human tumor cells. Cancer J 1995; 8: 94-102.
4. Wahl GM. The importance of circular DNA in mammalian gene amplification. Cancer Res 1989; 49: 1333-1340.
5. Meichle A, Philipp A, Eilers M. The functions of c-myc proteins. Bioch Biophys Acta 1992; 1114: 129-146.
6. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.
7. Shimizu N, Nakamura H, Kadota T, et al. Loss of amplified c-myc genes in the spontaneously differentiated HL-60 cells. Cancer Res 1994; 54: 3561-3567.
8. Von Hoff DD, McGill JR, Forseth BJ, et al. Elimination of extrachromosomal amplified myc genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci USA 1992; 89: 8165-8169.
9. Eckhardt SG, Dai A, Davidson KK, Forseth BJ, Wahl GM, Von Hoff DD. Induction of differentiation in HLA60 cells by the reduction of extrachromosomally amplified c-myc. Proc Natl Acad Sci USA 1994; 91: 6674-6678.
10. Von Hoff DD, Needham-VanDevanter DR, Yucel J, Windle BE, Wahl GM. Amplified human myc oncogenes localized to replicating submicroscopic circular DNA molecules. Proc Natl Acad Sci USA 1988; 85: 4804-4808.
11. Snapka RM, Varshavsky A. Loss of unstably amplified dihydrofolate reductase genes from mouse cells is greatly accelerated by hydroxyurea. Proc Natl Acad Sci USA 1983; 80: 7533-7537.
12. Watson PH, Safneck JR, Le K, Dubik D, Shiu RP. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 1993; 85: 902-907.
13. Tashiro H, Miyazaki K, Okamura H, Iwai A, Fukumoto M. C-myc over-expression in primary ovarian tumors. Int J Cancer 1992; 50: 828-833.
14. Smith DR, Myint T, Goh HS. Over-expression of c-myc in colorectal carcinoma. Br J Cancer 1993; 68: 407-413.
15. Ogunbiyi OA, Scholefield JH, Rogers K, Sharp F, Smith JH, Polacarz SV. C-myc expression in anal squamous neoplasia. J Clin Pathol 1993; 46: 23-37.
16. Volm M, Drings P, Wodrich W, Van Kaick G. Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastasis. J Clin Exp Met 1993; 11: 325-329.
17. Benner SE, Wahl GM, Von Hoff DD. Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines. Anti-Cancer Drugs 1991; 2: 11-25.
18. Von Hoff DD, Forseth B, Clare CN, Hansen KL, VanDevanter D. Double minutes arise from circular extrachromosomal DNA intermediates which integrate into chromosomal sites in human HL60 leukemia cells. J Clin Invest 1990; 85: 1887-1895.
19. Schoelein PV, Gottesman MM. Extrachromosomal DNA in human cancers. J Natl Cancer Inst 1990; 82: 1798-1800.
20. Stark GR. DNA amplification in drug resistant cells and tumors. Cancer Surv 1986; 5: 1-23.
21. Sklar MD, Prochownik EV. Modulation of cis-platinum resistance in friend erythroleukemia cells by c-myc. Cancer Res 1991; 51: 2118-2123.
22. Mizutani Y, Fukumoto M, Bonavida B, Yoshida O. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide. Cancer 1994; 74: 2546-2554.
23. Walker TL, White JD, Esdale WJ, Burton MA, De Cruz EE. Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression. Br J Cancer 1996; 73: 610-614.
24. Spandidos DA, Zoumpourlis V, Lang JC. Cisplatin responsive sequences in the human c-myc promoter. Anticancer Res 1991; 11: 1339-1342.
25. Swinnen LJ, Barnes DM, Fisher SG. 1-β-D-arabinofuranosylcytosine and hydroxyyurea production of cytotoxic synergy with cis-diamminedichloroplatinum and modification of platinum-induced DNA interstrand cross-linking. Cancer Res 1989; 49: 1383-1389.